Logo of brjcancerBJC HomepageBJC Advance online publicationBJC Current IssueSubmitting an article to BJCWeb feeds
Br J Cancer. 1983 May; 47(5): 629–640.
PMCID: PMC2011376

The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease.


Two hundred and eighty-eight primary breast tumours were examined for the presence or absence of oestrogen (REc) and progesterone (RPc) receptors. Analysis has shown a relative interdependence between the steroid receptor status of primary breast cancer and other prognostic variables such as histological grade, lymphocytic infiltration and tumour elastosis. There were significant associations between epithelial cellularity, stromal fibrosis and the value of REc in those tumours in which the receptor was present. Cellularity and fibrosis were unrelated to the presence or absence of oestrogen receptor. By contrast, neither the presence or absence nor the value of RPc could be related to cellularity or fibrosis. The value of REc and RPc analysis as an indicator of prognosis was examined in a sub-group of 175 patients receiving no additional treatment following mastectomy. Overall relapse-free survival (RFS) was no different for those patients with receptors compared to those without them (REc P = 0.11, RPc P = 0.7). There was no difference in RFS of receptor positive and negative tumours when the axillary node status was taken into account.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.4M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Allegra JC, Lippman ME, Simon R, Thompson EB, Barlock A, Green L, Huff KK, Do HM, Aitken SC, Warren R. Association between steroid hormone receptor status and disease-free interval in breast cancer. Cancer Treat Rep. 1979 Aug;63(8):1271–1277. [PubMed]
  • Antoniades K, Spector H. Correlation of estrogen receptor levels with histology and cytomorphology in human mammary cancer. Am J Clin Pathol. 1979 May;71(5):497–503. [PubMed]
  • Aspegren K, Håkansson L. Human mammary carcinoma studied for hormone responsiveness in short term incubations. Acta Chir Scand. 1974;140(2):95–99. [PubMed]
  • Barnes DM, Ribeiro GG, Skinner LG. Two methods for measurement of oestradiol-17 beta and progesterone receptors in human breast cancer and correlation with response treatment. Eur J Cancer. 1977 Oct;13(10):1133–1143. [PubMed]
  • Oestrogen receptors and survival in early breast cancer. Br Med J (Clin Res Ed) 1982 Feb 20;284(6315):597–598. [PMC free article] [PubMed]
  • Bishop HM, Blamey RW, Elston CW, Haybittle JL, Nicholson RI, Griffiths K. Relationship of oestrogen-receptor status to survival in breast cancer. Lancet. 1979 Aug 11;2(8137):283–284. [PubMed]
  • BLOOM HJ, RICHARDSON WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957 Sep;11(3):359–377. [PMC free article] [PubMed]
  • Cooke T, George WD, Griffiths K. Possible test for selection of adjuvant systemic therapy in early cancer of the breast. Br J Surg. 1980 Oct;67(10):747–750. [PubMed]
  • Cooke T, George D, Shields R, Maynard P, Griffiths K. Oestrogen receptors and prognosis in early breast cancer. Lancet. 1979 May 12;1(8124):995–997. [PubMed]
  • Croton R, Cooke T, Holt S, George WD, Nicolson R, Griffiths K. Oestrogen receptors and survival in early breast cancer. Br Med J (Clin Res Ed) 1981 Nov 14;283(6302):1289–1291. [PMC free article] [PubMed]
  • Eusebi V, Betts CM, Bussolati G. Tubular carcinoma: a variant of secretory breast carcinoma. Histopathology. 1979 Sep;3(5):407–419. [PubMed]
  • Feherty P, Farrer-Brown G, Kellie AE. Oestradiol receptors in carcinoma and benign disease of the breast: an in vitro assay. Br J Cancer. 1971 Dec;25(4):697–710. [PMC free article] [PubMed]
  • Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC. The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4). Cancer. 1975 Jul;36(1):1–85. [PubMed]
  • Forrest AP, Black RB, Humeniuk V, Cant EL, Hawkins RA, Prescott RJ, Roberts MM, Shivas AA, Stewart HJ, Smith AF, et al. Preoperative assessment and staging of breast cancer: preliminary communication. J R Soc Med. 1980 Aug;73(8):561–566. [PMC free article] [PubMed]
  • Hähnel R, Woodings T, Vivian AB. Prognostic value of estrogen receptors in primary breast cancer. Cancer. 1979 Aug;44(2):671–675. [PubMed]
  • Hilf R, Feldstein ML, Gibson SL, Savlov ED. The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer. Cancer. 1980 Apr 15;45(8):1993–2000. [PubMed]
  • Johansson H, Terenius L, Thorén L. The binding of estradiol-17beta to human breast cancers and other tissues in vitro. Cancer Res. 1970 Mar;30(3):692–698. [PubMed]
  • King RJ, Barnes DM, Hawkins RA, Leake RE, Maynard PV, Roberts MM. Measurement of oestradiol receptors by five institutions on common tissue samples. Br J Cancer. 1978 Sep;38(3):428–430. [PMC free article] [PubMed]
  • Kinne DW, Ashikari R, Butler A, Menendez-Botet C, Rosen PP, Schwartz M. Estrogen receptor protein in breast cancer as a predictor of recurrence. Cancer. 1981 May 15;47(10):2364–2367. [PubMed]
  • Knight WA, Livingston RB, Gregory EJ, McGuire WL. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res. 1977 Dec;37(12):4669–4671. [PubMed]
  • Korenman SG, Dukes BA. Specific estrogen binding by the cytoplasm fof human breast carcinoma. J Clin Endocrinol Metab. 1970 May;30(5):639–645. [PubMed]
  • Leclercq G, Heuson JC, Schoenfeld R, Mattheiem WH, Tagnon HJ. Estrogen receptors in human breast cancer. Eur J Cancer. 1973 Sep;9(9):665–673. [PubMed]
  • Martin PM, Rolland PH, Jacquemier J, Rolland AM, Toga M. Multiple steroid receptors in human breast cancer. II. Estrogen and progestin receptors in 672 primary tumors. Cancer Chemother Pharmacol. 1979;2(2):107–113. [PubMed]
  • Martin PM, Rolland PH, Jacquemier J, Rolland AM, Toga M. Multiple steroid receptors in human breast cancer. III. Relationships between steroid receptors and the state of differentiation and the activity of carcinomas throughout the pathologic features. Cancer Chemother Pharmacol. 1979;2(2):115–120. [PubMed]
  • Masters JR, Hawkins RA, Sangster K, Hawkins W, Smith II, Shivas AA, Roberts MM, Forrest AP. Oestrogen receptors, cellularity, elastosis and menstrual status in human breast cancer. Eur J Cancer. 1978 Mar;14(3):303–307. [PubMed]
  • Masters JR, Millis RR, King RJ, Rubens RD. Elastosis and response to endocrine therapy in human breast cancer. Br J Cancer. 1979 May;39(5):536–539. [PMC free article] [PubMed]
  • Masters JR, Sangster K, Hawkins RA, Shivas AA. Elastosis and oestrogen receptors in human breast cancer. Br J Cancer. 1976 Mar;33(3):342–343. [PMC free article] [PubMed]
  • Maynard PV, Blamey RW, Elston CW, Haybittle JL, Griffiths K. Estrogen receptor assay in primary breast cancer and early recurrence of the disease. Cancer Res. 1978 Nov;38(11 Pt 2):4292–4295. [PubMed]
  • Maynard PV, Davies CJ, Blamey RW, Elston CW, Johnson J, Griffiths K. Relationship between oestrogen-receptor content and histological grade in human primary breast tumours. Br J Cancer. 1978 Dec;38(6):745–748. [PMC free article] [PubMed]
  • McGuire WL, Horwitz KB, Pearson OH, Segaloff A. Current status of estrogen and progesterone receptors in breast cancer. Cancer. 1977 Jun;39(6 Suppl):2934–2947. [PubMed]
  • Millis RR, Rubens RD, Masters JR, Minton MJ. Histological grade and response to endocrine therapy in breast cancer. Lancet. 1981 Jul 11;2(8237):101–101. [PubMed]
  • Pichon MF, Pallud C, Brunet M, Milgrom E. Relationship of presence of progesterone receptors to prognosis in early breast cancer. Cancer Res. 1980 Sep;40(9):3357–3360. [PubMed]
  • Rasmussen BB, Rose C, Thorpe SM, Hou-Jensen K, Daehnfeldt JL, Palshof T. Histopathological characteristics and oestrogen receptor content in primary breast carcinoma. Virchows Arch A Pathol Anat Histol. 1981;390(3):347–351. [PubMed]
  • Rolland PH, Jacquemier J, Martin PM. Histological differentiation in human breast cancer is related to steroid receptors and stromal elastosis. Cancer Chemother Pharmacol. 1980;5(2):73–77. [PubMed]
  • Rosen PP, Menendez-Botet CJ, Nisselbaum JS, Urban JA, Miké V, Fracchia A, Schwartz MK. Pathological review of breast lesions analyzed for estrogen receptor protein. Cancer Res. 1975 Nov;35(11 Pt 1):3187–3194. [PubMed]
  • Sander S. The in vitro uptake of oestradiol in biopsies from 25 breast cancer patients. Acta Pathol Microbiol Scand. 1968;74(2):301–302. [PubMed]
  • Samaan NA, Buzdar AU, Aldinger KA, Schultz PN, Yang KP, Romsdahl MM, Martin R. Estrogen receptor: a prognostic factor in breast cancer. Cancer. 1981 Feb 1;47(3):554–560. [PubMed]
  • Say CC, Donegan WL. Invasive carcinoma of the breast: prognostic significance of tumor size and involved axillary lymph nodes. Cancer. 1974 Aug;34(2):468–471. [PubMed]
  • Shivas AA, Douglas JG. The prognostic significance of elastosis in breast carcinoma. J R Coll Surg Edinb. 1972 Sep;17(5):315–320. [PubMed]
  • Silverstrini R, Daidone MG, Di Fronzo G. Relationship between proliferative activity and estrogen receptors in breast cancer. Cancer. 1979 Aug;44(2):665–670. [PubMed]
  • Skinner LG, Barnes DM, Ribeiro GG. The clinical value of multiple steroid receptor assays in breast cancer management. Cancer. 1980 Dec 15;46(12 Suppl):2939–2945. [PubMed]
  • Terenius L, Johansson H, Rimsten A, Thorén L. Malignant and benign human mammary disease: estrogen binding in relation to clinical data. Cancer. 1974 May;33(5):1364–1368. [PubMed]
  • Thoresen S, Tangen M, Støa KF, Hartveit F. Oestrogen receptor values and histological grade in human breast cancer. Histopathology. 1981 May;5(3):257–262. [PubMed]
  • von Maillot K, Horke W, Prestele H. Prognostic significance of the steroid receptor content in primary breast cancer. Arch Gynecol. 1982;231(3):185–190. [PubMed]
  • Westerberg H, Gustafson SA, Nordenskjöld B, Silfverswärd C, Wallgren A. Estrogen receptor level and other factors in early recurrence of breast cancer. Int J Cancer. 1980 Oct 15;26(4):429–433. [PubMed]
  • Wittliff JL, Hilf R, Brooks WF, Jr, Savlov ED, Hall TC, Orlando RA. Specific estrogen-binding capacity of the cytoplasmic receptor in normal and neoplastic breast tissues of humans. Cancer Res. 1972 Sep;32(9):1983–1992. [PubMed]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK


Save items

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...